Daiwa Securities Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-126
| Closed | -$13K | – | 1356 |
|
|
2023
Q2 | $13K | Hold |
126
| – | – | ﹤0.01% | 1130 |
|
|
2023
Q1 | $11K | Buy |
126
+18
| +17% | +$1.06K | ﹤0.01% | 1110 |
|
|
2022
Q4 | $4K | Hold |
108
| – | – | ﹤0.01% | 1177 |
|
|
2022
Q3 | $3K | Hold |
108
| – | – | ﹤0.01% | 1212 |
|
|
2022
Q2 | $3K | Hold |
108
| – | – | ﹤0.01% | 1216 |
|
|
2022
Q1 | $4K | Hold |
108
| – | – | ﹤0.01% | 1204 |
|
|
2021
Q4 | $3K | Hold |
108
| – | – | ﹤0.01% | 1263 |
|
|
2021
Q3 | $11K | Buy |
108
+46
| +74% | +$5.39K | ﹤0.01% | 1133 |
|
|
2021
Q2 | $9K | Hold |
62
| – | – | ﹤0.01% | 1049 |
|
|
2021
Q1 | $6K | Buy |
62
+8
| +15% | +$933 | ﹤0.01% | 1073 |
|
|
2020
Q4 | $7K | Sell |
54
-106
| -66% | -$13.9K | ﹤0.01% | 1038 |
|
|
2020
Q3 | $16K | Buy |
160
+7
| +5% | +$875 | ﹤0.01% | 1013 |
|
|
2020
Q2 | $22K | Hold |
153
| – | – | ﹤0.01% | 1019 |
|
|
2020
Q1 | $22K | Hold |
153
| – | – | ﹤0.01% | 1002 |
|
|
2019
Q4 | $31K | Hold |
153
| – | – | ﹤0.01% | 988 |
|
|
2019
Q3 | $12K | Hold |
153
| – | – | ﹤0.01% | 1027 |
|
|
2019
Q2 | $14K | Hold |
153
| – | – | ﹤0.01% | 1038 |
|
|
2019
Q1 | $13K | Buy |
153
+43
| +39% | +$3.57K | ﹤0.01% | 1019 |
|
|
2018
Q4 | $6K | Hold |
110
| – | – | ﹤0.01% | 1048 |
|
|
2018
Q3 | $9K | Hold |
110
| – | – | ﹤0.01% | 1051 |
|
|
2018
Q2 | $4K | Hold |
110
| – | – | ﹤0.01% | 1111 |
|
|
2018
Q1 | $2K | Buy |
+110
| New | +$2.83K | ﹤0.01% | 1135 |
|
|
2017
Q2 | – | Sell |
-36,611
| Closed | -$829K | – | 1026 |
|
|
2017
Q1 | $829K | Buy |
+36,611
| New | +$904K | 0.01% | 484 |
|
Other funds holding RETA
Daiwa Securities Group's RETA Position: Q3 2023 in Review
Daiwa Securities Group sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 126 shares — an estimated $13K sold.
Daiwa Securities Group first reported a position in RETA in Q1 2017 and held it in 23 quarters. The position peaked at $829K in Q1 2017. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.
- Daiwa Securities Group reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Daiwa Securities Group sold 126 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $13K.
- Daiwa Securities Group first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2017 and held it in 23 quarters.
- Daiwa Securities Group's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $829K in Q1 2017.
- 2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.
Based on Daiwa Securities Group's 13F filing for Q3 2023, filed 1 Nov 2023.